96444 ⎘
Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B
EVOLUTION OF FLUOROGENIC SENSORS
#2RUTHENIUM COMPLEXES FOR INHIBITION OF GALECTINS, METHOD OF THEIR PREPARATION, AND USE THEREOF
#3IONIZABLE CATIONIC LIPIDS INCORPORATING SILICON: SYNTHESIS AND LNP FORMULATION
#4CONTRAST AGENTS FOR ENHANCED MAGNETIC RESONANCE IMAGING
#5TUMOR-SEEKING GLUCOSE-DENDRONS FOR THE DELIVERY OF CHEMOTHERAPEUTICS AND IMAGING AGENT TO CANCER CELLS
#6DIAGNOSTICS FOR DETECTING ECTO-5'-NUCLEOTIDASE (CD73)
#7METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON
#8TRITYL-BASED ALCOHOL PROTECTING GROUP
#9SILICON CONTAINING DETECTABLE COMPOUNDS
#10FLUORESCENT PROBE FOR LABELING M1 MACROPHAGES, AND M1 MACROPHAGE MONITORING SYSTEM USING SAME
#11COMPOSITIONS, KITS, AND METHODS TO INDUCE ACQUIRED CYTORESISTANCE USING STRESS PROTEIN INDUCERS
#125'-MODIFIED NUCLEOSIDE AND NUCLEOTIDE USING SAME
#13ANISOTROPIC LIGHT-EMITTING COLLOIDAL KAGOME SUPERLATTICES
#14NUCLEOTIDE COMPLEXES CAPABLE OF AN IMPROVED DNA SYNTHESIS YIELD
#15ACETYLATED SIALIC ACID GLYCOCLUSTERS AND THEIR USES FOR TREATING INFECTIOUS DISEASES
#16SUBSTRATES FOR IMAGING GLUCOCEREBROSIDASE ACTIVITY
#17SAPONIN-BASED ADJUVANTS AND VACCINES
#18NUCLEOSIDE PHOSPHORAMIDATES
#19PHOSPHOROAMIDATE ESTERS, AND USE AND SYNTHESIS THEREOF
#20FLUORESCENT DYES CONTAINING BIS-BORON FUSED HETEROCYCLES AND USES IN SEQUENCING
#21IMMUNE MEMORY INDUCTION BY PLATINUM BASED COMPOUNDS
#22GLUCOSE DERIVATIVES AND ANTICANCER AGENT USING SAME
#23NEW SYNTHETIC AGONISTS OF TLR4 RECEPTOR
#24IRON COMPLEX COMPOUNDS FOR THERAPUTIC USE
#25Terminal alkenyl functional silylated polysaccharides
#26CHIMERIC NUCLEIC ACID OLIGOMER INCLUDING PHOSPHOROTHIOATE AND BORANOPHOSPHATE, AND METHOD FOR PRODUCING SAME
#27ORGANOPOLYSILOXANE-MODIFIED CYCLODEXTRIN COMPOUND AND COSMETICS CONTAINING SAME
#28SEPARATION OF METAL IONS FROM A SAMPLE USING GLYCOLIPIDS
#29Sugar Derivatives and Uses Thereof to Prepare Novel Senolytic Agents
#30Transcriptome In Vivo Analysis (TIVA) and Transcriptome In Situ Analysis (TISA)
#31Spin-Labeled Nucleosides and Phosphoramidites
#32DEOXYNUCLEOSIDE MODIFIED RUTHENIUM COMPLEX, AND PREPARATION METHOD AND USE THEREOF
#33Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
#34NOVEL, HEAVY VITAMIN B12 DERIVATIVES
#35NOVEL IRON COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#36Synthesis of 2′ protected nucleosides
#37OLIGONUCLEOTIDES, REAGENTS, AND PREPARATION THEREOF
#38SILICON CONTAINING DETECTABLE COMPOUNDS
#39SILICON CONTAINING MODIFIED NUCLEOTIDE ANALOGS
#40Heavy vitamin B12 derivatives
#41Manufacturing Method for Polynuclear Iron Compounds Stabilized by Carbohydrates and/or Humic Acid
#42METAL-CARBOHYDRATE COMPLEX
#43Sugar derivatives and uses thereof to prepare novel senolytic agents
#44Iron compositions and methods of making and using the same
#45METHOD FOR PRODUCING GLYCOSIDE COMPOUND
#46METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON
#47Fluorescent dyes containing bis-boron fused heterocycles and uses in sequencing
#48COBALAMIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF DISEASES CAUSED BY LACK OF VITAMIN B12 SUPPLY
#49HYDROCINNAMOYL PROTECTED RIBOGUANOSINE PHOSPHORAMIDITES FOR DECREASING DEPYRIMIDINATION FROM ALKYL AMINE EXPOSURE DURING FINAL DEPROTECTION
#50NOVEL SPIROBICYCLIC INTERMEDIATES
#51Iron compositions and methods of making and using the same
#52Bifunctional nucleoside hydrogel, preparation method therefor and use thereof
#53MODIFIED NUCLEOSIDE AND SYNTHETIC METHODS THEREOF
#54ASYMMETRIC AUXILIARY GROUP
#55PHOSPHOROAMIDATE ESTERS, AND USE AND SYNTHESIS THEREOF
#56IRON COMPLEX COMPOUNDS FOR THERAPUTIC USE
#57Method for producing glycoside compound
#58Transcriptome in vivo analysis (TIVA) and transcriptome in situ analysis (TISA)
#59METHOD OF PREPARING NUCLEASE-RESISTANT DNA-INORGANIC HYBRID NANOFLOWERS
#60Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
#61Host-guest metal organic framework systems
#62Process for the preparation of hydroxocobalamin hydrochloride
#63Amidite compound and method for producing polynucleotide using said compound
#644'-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS AND PREPARATIONS THEREOF
#65Heavy vitamin B12 derivatives
#66ORGANICALLY MODIFIED MINERAL MICRO-PARTICLES, METHODS OF PREPARING THE SAME AND USES THEREOF
#67Development of Imaging and Therapeutic Glucose Analogues for Sodium Dependent Glucose Transporters
#68Polymyxin-based pharmaceutical composition for treating infectious diseases
#69Prodrug-type anticancer agent using cancer-specific enzymatic activity
#70Asymmetric auxiliary group
#71Stereoselective synthesis and process for the manufacturing of 2′-deoxynucleosides
#72LIPID-BASED PLATINUM COMPOUNDS AND NANOPARTICLES
#73Process for the purification of methylcobalamin
#74Iron compositions and methods of making and using the same
#75Methods and compositions for administration of iron
#76Methods and compositions for administration of iron
#77Method and kit for detection of cyanide
#78Cobalamin derivatives and their use for the treatment of diseases caused by lack of vitamin B12 supply
#79PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS
#80Silicon containing detectable compounds
#81SEPARATION OF OLIGOSACCHARIDES FROM FERMENTATION BROTH
#82Phosphoroamidate esters, and use and synthesis thereof
#83Methods and compositions for administration of iron
#84Substituted boric acid compound, pharmaceutical composition comprising same, and application thereof
#85IMMUNE MEMORY INDUCTION BY PLATINUM BASED COMPOUNDS
#86DNA-Mn hybrid particles and method of manufacturing the same
#87Asymmetric auxiliary group
#88Iron complex compounds for therapeutic use
#89Boron-containing compound
#90KIF13B-derived peptide and method of inhibiting angiogenesis
#91Polyene macrolide derivative
#92COMPOUNDS LINKED WITH A SACCHARIDE METAL COMPLEX AND USES THEREOF
#93COMPLEXES OF NUCLEIC ACID MOLECULES AND METALS
#94Multivalent saccharide complex, radioactive multivalent saccharide complex contrast agent, and use thereof
#95Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
#96HCV POLYMERASE INHIBITORS
#97Methods and compositions for administration of iron
#98METHODS OF SYNTHESIZING LABELED NUCLEOSIDES
#99Regioselective silyl exchange of per-silylated oligosaccharides
#100Separation of oligosaccharides from fermentation broth
#1014′-Substituted nucleoside reverse transcriptase inhibitors and preparations thereof
#102Lipid-based platinum compounds and nanoparticles
#103Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same
#104METHOD OF PREPARING NUCLEASE-RESISTANT DNA-INORGANIC HYBRID NANOFLOWERS
#105Method of preparation of 6-azido-2,4-diacetamido-2,4,6-trideoxy-D-mannose
#106Transition metal molybdotungsten oxy-hydroxide
#107THE SCANO-miR PLATFORM IDENTIFIES A DISTINCT CIRCULATING MICRORNA SIGNATURE FOR THE DIAGNOSIS OF DISEASE
#108Methods and compositions for administration of iron
#109Compositions and methods for borocarbohydrate complexes
#110COMPLEXES FOR INTRACELLULAR IMAGING
#111Protected monomer and method of final deprotection for RNA synthesis
#112Methods of preparing substituted nucleoside analogs
#113Silyl etherified derivatives of 5-azacytidines in carbohydrate moiety
#114HCV polymerase inhibitors
#115Processes and intermediates for preparing anti-HIV agents
#116Method for producing glycoside compounds
#117METHOD FOR PREPARING PRECURSOR OF GENE EXPRESSION PROBE
#118Heavy vitamin B12 derivatives
#119Separation of oligosaccharides from fermentation broth
#120Oligonucleotide having non-natural nucleotide at 5′-terminal thereof
#121Precipitation promoter and precipitation method in which same is used
#122Ruthenium-based photolinkers and methods of use
#123Transcriptome in vivo analysis (TIVA) and transcriptome in situ analysis (TISA)
#124A Nucleoside Derivative For Use As A Drug, Particularly For The Treatment Of Chronic Lymphocytic Leukemia
#125Templated molecules and methods for using such molecules
#126Polyene macrolide derivative
#127Host-guest metal organic framework systems
#128Transition metal molybdotungsten oxy-hydroxide
#129Labeled Nucleic Acids: A Surrogate for Nanopore-based Nucleic Acid Sequencing
#130Boron-based prodrug strategy for increased bioavailability and lower-dosage requirements for drug molecules containing at least one phenol (or aromatic hydroxyl) group
#131Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
#132UBA5 inhibitors
#133HCV polymerase inhibitors
#134C-glycoside derivative
#135Duplex-selective organometallic DNA intercalators
#136BORON-CONTAINING SMALL MOLECULES
#137METHOD OF DETECTING PEROXYNITRITE USING A COMPLEX OF A SACCHARIDE AND AN ARYLBORONATE-BASED FLUORESCENT PROBE
#138Asymmetric auxiliary group
#139Asymmetric bifunctional silyl monomers and particles thereof as prodrugs and delivery vehicles for pharmaceutical, chemical and biological agents
#140Preparation of monosaccharides, disaccharides, trisaccharides, and pentasaccharides of heparinoids
#141Compositions and methods for borocarbohydrate complexes
#142Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same
#143Processes and intermediates for preparing anti-HIV agents
#144Process for the preparation of empagliflozin
#145Method of making complex nano particles and using the same to reduce cell viability
#146Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
#147β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N-substituted purine nucleotides for HCV treatment
#148Ruthenium carbon monoxide releasing molecules and uses thereof
#149Boron-containing small molecules
#150Process for the preparation of benzylbenzene SGLT2 inhibitors
#151Boron-containing small molecules
#152Virus detection
#153CANCER CELL SPECIFIC IMAGING PROBES AND METHODS OF USE
#154Boron-containing small molecules
#155Regioselective silyl exchange of per-silylated oligosaccharides
#156Glycoside compound, method for producing thioether, ether, method for producing ether, method for producing glycoside compound, method for producing nucleic acid
#157RADIATION ENHANCED MACROMOLECULAR DELIVERY OF THERAPEUTIC AGENTS FOR CHEMOTHERAPY
#158Boron-containing small molecules
#159Phosphoroamidate esters, and use and synthesis thereof
#160Lipid-based platinum compounds and nanoparticles
#161Method for preparing metal nanostructure based on biomolecules
#162Lipid-based platinum-N-heterocyclic carbene compounds and nanoparticles
#163Methods of preparing substituted nucleoside analogs
#164Intermediate for production of nucleoside analog and method for producing the same
#165Heparan sulfate synthesis
#166Compositions and methods for borocarbohydrate complexes
#167Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl) cytosine, synthetic intermediate of thionucleoside, and method for producing the same
#168Ultrastable silver nanoparticles
#169Protected monomer and method of final deprotection for RNA synthesis
#170Water-soluble complexing agents and corresponding lanthanide complexes
#171Protecting groups for “Z nucleotide” and methods thereof
#172METHODS AND INTERMEDIATES FOR THE PREPARATION OF FONDAPARINUX
#173Templated molecules and methods for using such molecules
#174Methods and compositions for administration of iron
#175Oligonucleotide and artificial nucleoside having guanidine bridge
#176Synthesis of deuterated ribo nucleosides, N-protected phosphoramidites and oligonucleotides
#177Co-modified organopolysiloxane, and powder treatment agent and powder composition comprising the same
#178Inflammation imaging and therapy
#179Exocyclic nitrogen atom protected nucleoside and method for producing and using the same
#180Selective oxidation of carbohydrates
#181Processes and intermediates for preparing anti-HIV agents
#182Asymmetric auxiliary group
#183Synthetic pGpG analogs, methods of preparation and methods of use
#184Intermediate for production of nucleoside analog and method for producing the same
#185Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same
#186PROCESS FOR PREPARATION OF IRON SUCROSE
#187Complex compounds of germanium, methods for producing same, and drugs
#188Methods and intermediates for the preparation of fondaparinux
#189Method for protecting hydroxyl or amine or thiol functions, novel compounds with protected hydroxyl or amine or thiol groups, as well novel compounds for the implementation of this method
#190Synthesis and uses of nucleic acid compounds with conformationally restricted monomers
#191Asymmetric bifunctional silyl monomers and particles thereof as prodrugs and delivery vehicles for pharmaceutical, chemical and biological agents
#192WATER SOLUBLE PLATINUM COMPLEXES FOR TUMOR TREATMENT AND PROCESS OF PREPARING SAME
#1932′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections
#194FLUORINE-CONTAINING WATER SOLUBLE PLATINUM COMPLEXES FOR TUMOR TREATMENT AND PROCESS OF PREPARING SAME
#195Amino sugar-bound anti-cancerous noble metal complex
#196Metallodrugs Having Improved Pharmacological Properties, and Methods of Manufacture and Use Thereof
#197USE OF FLUORINE-CONTAINING WATER SOLUBLE PLATINUM COMPLEX IN PREPARING DRUGS FOR PREVENTION AND TREATMENT OF CANCERS
#198Process for the preparation of trivalent iron complexes with mono-, di- and polysaccharide sugars
#199PROCESS FOR THE PREPARATION OF CERTAIN TRIARYL RHAMNOSE CARBAMATES
#200METHODS OF PRODUCING C-ARYL GLUCOSIDE SGLT2 INHIBITORS
#201Silica particles coated with β-cyclodextrin for the removal of emerging contaminants from wastewater
#202Compositions, methods of synthesis and use of carbohydrate targeted agents
#203Boron-containing small molecules
#204Ruthenium carbon monoxide releasing molecules and uses thereof
#205Glycoside compound, method for producing thioether, ether, method for producing ether, method for producing glycoside compound, method for producing nucleic acid
#206Saccharide structures and methods of making and using such structures
#207Boronic acid derivatives and therapeutic uses thereof
#208Methods for pathogen detection and disease treatment
#209(Meth)allylsilane compound, silane coupling agent therefor, and functional material using same
#210Gemcitabine prodrugs and uses thereof
#211Methods and compositions for administration of iron
#212SUBSTRATES COMPRISING SWITCHABLE FERROMAGNETIC NANOPARTICLES
#213Boranophosphate analogues of cyclic nucleotides
#2142′-O-aminooxymethyl nucleoside derivatives for use in the synthesis and modification of nucleosides, nucleotides and oligonucleotides
#215GLUCOPYRANOSYL-SUBSTITUTED PHENYL DERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE
#216Synthesis of deuterated ribo nucleosides N-protected phosphoramidites, and oligonucleotides
#217Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
#218Synthetic lipid A derivative
#2191,2,3-Triazolyl purine derivatives
#220Uridine-based gadolinium complex and MRI contrast agent including the same
#221Ketolide compounds
#222Compositions for the treatment or prophylaxis of viral infections
#223Uridine di- or tri-phosphate derivatives and uses thereof
#224Nucleic acid construct and method of preparing nanoparticle using the same
#225TARGETED SCHIFF BASE COMPLEXES
#226Nucleoside phosphoramidates
#227Process for the preparation of benzylbenzene SGLT2 inhibitors
#2282'-O-modified RNA
#229METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON
#230Purification of synthetic oligonucleotides
#231ASYMMETRIC BIOFUNCTIONAL SILYL MONOMERS AND PARTICLES THEREOF AS PRODRUGS AND DELIVERY VEHICLES FOR PHARMACEUTICAL, CHEMICAL AND BIOLOGICAL AGENTS
#232Nucleotides and aptamers containing boronic acid groups having biased binding to glycosylated proteins, and uses thereof
#233Metal particles for surface-enhanced raman scattering and molecular sensing
#234Methods for the synthesis and purification of oligomers
#235COMPOSITION IN THE FORM OF LIQUID FOR MAINTENANANCE OF CONTACT LENSES AND MEDICAL MATERIALS
#236METHODS AND COMPOSITIONS RELATED TO MODIFIED ADENOSINES FOR CONTROLLING OFF-TARGET EFFECTS IN RNA INTERFERENCE
#237Low molecular weight complexes between iron and maltobionic acid, use thereof for intramuscular or subcutaneous administration in the treatment of anemic states, and new pharmaceutical compositions adapted for these uses
#238Biphotonic photosensitizers, nanoparticles containing the same and their use as drugs
#239BORON-CONTAINING SMALL MOLECULES
#240BORON-CONTAINING SMALL MOLECULES
#241OLIGOSACCHARIDE/SILICON-CONTAINING BLOCK COPOLYMERS FOR LITHOGRAPHY APPLICATIONS
#242GLUCOPYRANOSYL-SUBSTITUTED PHENYL DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE
#243Processes and intermediates for preparing anti-HIV Agents
#244Protected monomer and method of final deprotection for RNA synthesis
#245Boron-containing small molecules
#246Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof
#247Method of selecting an agent that improves periodontal disease
#248PROCESS FOR THE PREPARATION OF IRON (III) CARBOXYMALTOSE COMPLEX
#249Bridged artificial nucleoside and nucleotide
#250RADIATION ENHANCED MACROMOLECULAR DELIVERY OF THERAPEUTIC AGENTS FOR CHEMOTHERAPY TECHNOLOGY
#251PROTECTED MONOMERS AND METHODS OF DEPROTECTION FOR RNA SYNTHESIS
#252SYNTHESIS OF CYCLIC DIGUANOSINE MONOPHOSPHATE AND THIOPHOSPHATE ANALOGS THEREOF
#253Oligonucleotides useful for detecting and analyzing nucleic acids of interest
#254COMPOUNDS FOR THE SYNTHETIC INTRODUCTION OF N-ALKYL NUCLEOSIDES INTO DNA OLIGONUCLEOTIDES
#2552′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections
#256HEPARAN SULFATE SYNTHESIS
#257Bismuth-containing compounds, coordination polymers, methods for modulating pharmacokinetic properties of biologically active agents, and methods for treating patients
#2582-fluorinated riboses and arabinoses and methods of use and synthesis
#259Based-assisted formation of tin-sucrose adducts
#260Polyhedraltransition metal complex, transition metal complex containing ultrafine particles therein, and process for producing same
#261Process for producing nucleoside
#2626′-sialyllactose salts and process for their synthesis and for the synthesis of other alpha-sialyloligosaccharides
#263Synthesis of labile base protected-modified deoxy and modified ribo nucleosides, corresponding phosphoramidites and supports and their use in high purity oligonucleotide synthesis
#264METHOD AND COMPOSITIONS
#265Method of using autoinducer-2 as a periodontal disease marker
#266Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
#267SYNTHETIC LIPID A DERIVATIVE
#268Reagents for reversibly terminating primer extension
#269Nucleoside phosphoramidates
#270NUCLEOSIDE ANALOGUES USEFUL AS POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AGENTS
#271NUCLEOTIDE TRIPHOSPHATE WITH AN ELECTROACTIVE LABEL CONJUGATED TO THE GAMMA PHOSPHATE
#272Saccharide structures and methods of making and using such structures
#273Methods of Producing C-Aryl Glucoside SGLT2 Inhibitors
#274GLUCOPYRANOSYL-SUBSTITUTED PHENYL DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE
#275Substrates comprising switchable ferromagnetic nanoparticles
#276Methods and compositions for imaging cancer cells
#277TARGETED SCHIFF BASE COMPLEXES
#278Fluorinated fructose derivatives for PET imaging
#279METHOD OF DETOXIFYING A HARMFUL COMPOUND
#280Boron-containing small molecules
#281Methods and compositions for administration of iron
#282Compositions for the treatment or prophylaxis of viral infections
#283Synthetic lipid A derivative
#284Carbohydrate-metallocene-antimalarial conjugates
#285Diagnostic And Radiotherapeutic Contrast Agents And Process For Their Preparation
#286Non-fouling, anti-microbial, anti-thrombogenic graft—from compositions
#287Bis-modified bicyclic nucleic acid analogs
#288PHOTOREACTIVE RU (II) COMPLEXES ANCHORED ON OLIGONUCLEOTIDES, METHOD FOR OBTAINING THEM AND USE THEREOF
#289FLUORESCENT NUCLEOSIDE ANALOGUES
#290Caged nucleotides and oligonucleotides and their application
#291Fluorous Oligonucleotide Reagents and Affinity Purification of Oligonucleotides
#292PROTECTED MONOMER AND METHOD OF FINAL DEPROTECTION FOR RNA SYNTHESIS
#2934′-allene-substituted nucleoside derivatives
#294Nucleic Acid Mediated Electron Transfer
#295Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
#296Templated molecules and methods for using such molecules
#297Extended Length Borane Phosphonate Nucleic Acid Compounds
#298GLUCOPYRANOSYL-SUBSTITUTED PHENYL DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE
#299Cost-effective process for preparation of manufacture of iron sucrose
#3002'-Modified Oligonucleotides